Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Peptides as potential therapeutics for Alzheimer's disease
ID
Ribarič, Samo
(
Author
)
PDF - Presentation file,
Download
(605,13 KB)
MD5: B4121759E674B4AB9D682E8B168870C0
URL - Source URL, Visit
http://www.mdpi.com/1420-3049/23/2/283
Image galllery
Abstract
Intracellular synthesis, folding, trafficking and degradation of proteins are controlled and integrated by proteostasis. The frequency of protein misfolding disorders in the human population, e.g., in Alzheimer's disease (AD), is increasing due to the aging population. AD treatment options are limited to symptomatic interventions that at best slow-down disease progression. The key biochemical change in AD is the excessive accumulation of per-se non-toxic and soluble amyloid peptides (Aβ(1-37/44), in the intracellular and extracellular space, that alters proteostasis and triggers Aβ modification (e.g., by reactive oxygen species (ROS)) into toxic intermediate, misfolded soluble Aβ peptides, Aβ dimers and Aβ oligomers. The toxic intermediate Aβ products aggregate into progressively less toxic and less soluble protofibrils, fibrils and senile plaques. This review focuses on peptides that inhibit toxic Aβ oligomerization, Aβ aggregation into fibrils, or stabilize Aβ peptides in non-toxic oligomers, and discusses their potential for AD treatment.
Language:
English
Keywords:
Alzheimer's disease
,
amyloid β oligomers
,
amyloid β peptide
,
aggregation
,
amyloid β plaques
,
insulin
,
neurofibrillary tangles
,
tau protein
,
peptides
,
peptide therapy
Work type:
Article
Typology:
1.02 - Review Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2018
Number of pages:
31 str.
Numbering:
Vol. 23, iss. 2, art. 283
PID:
20.500.12556/RUL-131869
UDC:
616.8
ISSN on article:
1420-3049
DOI:
10.3390/molecules23020283
COBISS.SI-ID:
33689817
Publication date in RUL:
05.10.2021
Views:
1985
Downloads:
160
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Molecules
Shortened title:
Molecules
Publisher:
MDPI
ISSN:
1420-3049
COBISS.SI-ID:
18462981
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
01.02.2018
Secondary language
Language:
Slovenian
Keywords:
Alzheimerjeva bolezen
,
amiloidni β oligomeri
,
amiloidni peptid
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0171
Name:
Plastičnost živčevja v fizioloških in patofizioloških razmerah
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back